Philippines vs Tunisia: Reported cases of paralytic polio by world region
Philippines
0 cases
in 2023
Tunisia
0 cases
in 2023
Philippines rank
26th
Tunisia rank
26th
Reported cases of paralytic polio by world region over time
- Philippines
- Tunisia
How they compare
Philippines currently reports 0 cases against 0 cases in Tunisia, a difference of 0 cases.
The two have swapped places 5 times across 44 shared years of data; in 1980 it was Philippines ahead.
Philippines ranks 26th and Tunisia ranks 26th of 199 countries.
Philippines has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Philippines | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 368.9 cases | 14.2 cases | 354.7 cases | Philippines |
| 1990s | 25.6 cases | 0.7 cases | 24.9 cases | Philippines |
| 2000s | 0.3 cases | 0 cases | 0.3 cases | Philippines |
| 2010s | 1.4 cases | 0 cases | 1.4 cases | Philippines |
| 2020s | 0.25 cases | 0 cases | 0.25 cases | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Philippines or Tunisia?
- Philippines, at 0 cases against 0 cases in Tunisia as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Philippines and Tunisia?
- 0 cases, with Philippines ahead.
- How many years of comparable data are there for Philippines and Tunisia?
- 44 years are reported by both, from 1980 to 2023.
- How do Philippines and Tunisia rank globally for reported cases of paralytic polio by world region?
- Philippines ranks 26th and Tunisia ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.